Clinical effectiveness of prednisolone oral administration for esophageal stricture after endoscopic submucosal dissection.

Clinical effectiveness of prednisolone oral administration for esophageal stricture after endoscopic submucosal dissection. - Post-ESD esophageal strictures and prednisolone

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000016178

Enrollment

Registered

2015-01-11

Start date

2010-02-26

Completion date

Unknown

Last updated

2025-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

esophageal neoplasm

Interventions

oral prednisolone

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria:

Exclusion criteria

Exclusion criteria: presence of related complications

Design outcomes

Secondary

Measure	Time frame
times of preventive endoscopic balloon dilatation	—

Primary

Measure	Time frame
prevention of esophageal stricture presence of the stricture-related symptoms	—

Countries

Japan

Contacts

Public ContactHajime Isomoto

Nagasaki University Hospital Endoscopy

hajimei2002@yahoo.co.jp095-819-7336

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Feb 4, 2026